Beckman Coulter, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$19Mgeneral payments (2019-2025)
$24Kresearch payments (2019-2025)
1,150clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $2.0M
2020 $2.4M
2021 $2.6M
2022 $2.7M
2023 $2.8M
2024 $3.1M
2025 $3.0M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Hematology & Oncology $15M
Internal Medicine $392K
Emergency Medicine $346K
Anatomic Pathology & Clinical Pathology $124K
Cardiovascular Disease $108K
Pulmonary Disease $67K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
John Pesando Seattle, WA Hematology & Oncology $15,068,170.28
Brian Harvey Annapolis, MD Internal Medicine $106,500.00
David Shulkin Morristown, NJ Internal Medicine $90,455.32
Phillip Levy Detroit, MI Emergency Medicine $86,570.19
Nima Sarani Kansas City, KS Emergency Medicine $65,070.02
Alan Wright Sparks, MD Internal Medicine $64,679.42
Brandon Allen Gainesville, FL Emergency Medicine $59,626.37
Jessica Guidi Providence, RI Advanced Heart Failure and Transplant Cardiology $41,062.50
Yasir Tarabichi Cleveland, OH Pulmonary Disease $40,575.00
Daniel Spyker Camas, WA Internal Medicine $39,130.00

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.